Daniel S Pratt

Publication Activity (10 Years)

Years Active: 2023-2023
Publications (10 Years): 2

Top Topics

Atopic Dermatitis

Placebo Controlled

Top Venues

Hepatology (Baltimore, Md.)

Hepatology communications

This page only lists publications with an associated author ORCID identifier.

Publications

Henry E Pratt, Tong Wu, Shaimae Elhajjajy, Jeffrey Zhou, Kate Fitzgerald, Tom Fazzio, Zhiping Weng, Daniel S Pratt
Beyond genome-wide association studies: Investigating the role of noncoding regulatory elements in primary sclerosing cholangitis. Hepatology communications 7 (10) (2023)
Gideon M Hirschfield, Mitchell L Shiffman, Gideon M Hirschfield, Kris V Kowdley, John M Vierling, Cynthia Levy, Andreas E Kremer, Ehud Zigmond, Pietro Andreone, Stuart C Gordon, Christopher L Bowlus, Eric J Lawitz, Richard J Aspinall, Daniel S Pratt, Karina Raikhelson, Maria S Gonzalez-Huezo, Michael A Heneghan, Sook-Hyang Jeong, Alma L Ladrón de Guevara, Marlyn J Mayo, Georgios N Dalekos, Joost Paulus Hubertus Drenth, Ewa Janczewska, Barbara A Leggett, Frederik Nevens, Víctor Vargas, Eli Zuckerman, Christophe Corpechot, Eduardo Fassio, Holger Hinrichsen, Invernizzi Pietro, Palak J Trivedi, Lisa Forman, David E J Jones, Stephen D Ryder, Mark G Swain, Alexandra Steinberg, Pol F Boudes, Yun-Jung Choi, Charles A McWherter, null null
Seladelpar efficacy and safety at 3 months in patients with primary biliary cholangitis: ENHANCE, a phase 3, randomized, placebo-controlled study. Hepatology (Baltimore, Md.) (2023)